212 related articles for article (PubMed ID: 16705028)
1. How many "Me-Too" drugs are enough? The case of physician preferences for specific statins.
Austin PC; Mamdani MM; Juurlink DN
Ann Pharmacother; 2006 Jun; 40(6):1047-51. PubMed ID: 16705028
[TBL] [Abstract][Full Text] [Related]
2. Case selection for statins was similar in two Canadian provinces: BC and Ontario.
Paterson JM; Carney G; Anderson GM; Bassett K; Naglie G; Laupacis A;
J Clin Epidemiol; 2007 Jan; 60(1):73-8. PubMed ID: 17161757
[TBL] [Abstract][Full Text] [Related]
3. Quantifying the use of the statin antilipemic drugs: comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia.
Cooke C; Nissen L; Sketris I; Tett SE
Clin Ther; 2005 Apr; 27(4):497-508. PubMed ID: 15922822
[TBL] [Abstract][Full Text] [Related]
4. A population-based analysis of statin utilization in British Columbia.
Raymond CB; Morgan SG; Katz A; Kozyrskyj AL
Clin Ther; 2007 Sep; 29(9):2107-19. PubMed ID: 18035209
[TBL] [Abstract][Full Text] [Related]
5. Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial.
Pimlott NJ; Hux JE; Wilson LM; Kahan M; Li C; Rosser WW
CMAJ; 2003 Apr; 168(7):835-9. PubMed ID: 12668540
[TBL] [Abstract][Full Text] [Related]
6. Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003.
Walley T; Folino-Gallo P; Stephens P; Van Ganse E
Br J Clin Pharmacol; 2005 Nov; 60(5):543-51. PubMed ID: 16236045
[TBL] [Abstract][Full Text] [Related]
7. Statin prescribing in Australia: socioeconomic and sex differences. A cross-sectional study.
Stocks NP; Ryan P; McElroy H; Allan J
Med J Aust; 2004 Mar; 180(5):229-31. PubMed ID: 14984343
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of educational outreach to improve evidence-based prescribing in Medicaid: a cautionary tale.
Zillich AJ; Ackermann RT; Stump TE; Ambuehl RJ; Downs SM; Holmes AM; Katz B; Inui TS
J Eval Clin Pract; 2008 Oct; 14(5):854-60. PubMed ID: 19018918
[TBL] [Abstract][Full Text] [Related]
9. Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in France.
Pichetti S; Sermet C; Godman B; Campbell SM; Gustafsson LL
Appl Health Econ Health Policy; 2013 Jun; 11(3):205-18. PubMed ID: 23609765
[TBL] [Abstract][Full Text] [Related]
10. Pattern of statins' utilization at Ramathobodi Hospital, 2005 to 2007.
Pattanaprateep O; Pongcharoensuk P; Suvanakoot P; Kaojarern S
J Med Assoc Thai; 2010 Oct; 93(10):1223-31. PubMed ID: 20973328
[TBL] [Abstract][Full Text] [Related]
11. Understanding the effects of a decentralized budget on physicians' compliance with guidelines for statin prescription--a multilevel methodological approach.
Ohlsson H; Merlo J
BMC Health Serv Res; 2007 May; 7():68. PubMed ID: 17488496
[TBL] [Abstract][Full Text] [Related]
12. Statins prescribing for the secondary prevention of ischaemic heart disease in Torino, Italy. A case of ageism and social inequalities.
Gnavi R; Migliardi A; Demaria M; Petrelli A; Caprioglio A; Costa G
Eur J Public Health; 2007 Oct; 17(5):492-6. PubMed ID: 17303583
[TBL] [Abstract][Full Text] [Related]
13. Prescribing trends by nurse practitioners and physician assistants in the United States.
Cipher DJ; Hooker RS; Guerra P
J Am Acad Nurse Pract; 2006 Jun; 18(6):291-6. PubMed ID: 16719848
[TBL] [Abstract][Full Text] [Related]
14. Using a computerized drug prescription screening system to trace drug interactions in an outpatient setting.
Morera T; Gervasini G; Carrillo JA; Benitez J
Ann Pharmacother; 2004; 38(7-8):1301-6. PubMed ID: 15178735
[TBL] [Abstract][Full Text] [Related]
15. Is physician adherence to prescription guidelines a general trait of health care practices or dependent on drug type?--a multilevel logistic regression analysis in South Sweden.
Ohlsson H; Merlo J
Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):682-90. PubMed ID: 19437457
[TBL] [Abstract][Full Text] [Related]
16. How complete are drug history profiles that are based on public drug benefit claims?
Paterson JM; Suleiman A; Hux JE; Bell C
Can J Clin Pharmacol; 2008; 15(1):e108-16. PubMed ID: 18283220
[TBL] [Abstract][Full Text] [Related]
17. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals.
Bradford WD; Kleit AN; Nietert PJ; Ornstein S
Clin Ther; 2006 Dec; 28(12):2105-18; discussion 2104. PubMed ID: 17296467
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a drug-drug interaction alert structure through the retrospective analysis of statins-macrolides co-prescriptions.
Morera T; Gervasini G; Carrillo JA; Benitez J
Basic Clin Pharmacol Toxicol; 2005 Apr; 96(4):289-94. PubMed ID: 15755311
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
[TBL] [Abstract][Full Text] [Related]
20. The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium.
Fraeyman J; Van Hal G; Godman B; Beutels P
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):141-51. PubMed ID: 23402454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
